KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like The Philippines Suspends Sanofi's Dengue Vaccine After 730,000+ Children are Immunized December 3, 2017 Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA February 15, 2017 New Jersey Startup Launches With Clinical Assets From Big Name Biotechs August 21, 2017
The Philippines Suspends Sanofi's Dengue Vaccine After 730,000+ Children are Immunized December 3, 2017
Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA February 15, 2017
